Related Experiment Video
Updated: Oct 26, 2025

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision
Published on: May 2, 2025
Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia
Lynette Goh1, Kong Boo Phua1, Yee Low2
1Gastroenterology, Hepatology & Nutrition Service, Pediatric Medicine, KK Women's and Children's Hospital, Singapore.
Insights
Extended perioperative antibiotics and corticosteroids did not improve outcomes for biliary atresia patients after Kasai portoenterostomy. Further research is needed to optimize adjuvant therapies for biliary atresia (BA).
Area of Science:
- Pediatric Surgery
- Hepatology
- Gastroenterology
Background:
- Biliary atresia (BA) is a serious neonatal liver disease requiring surgical intervention.
- Kasai portoenterostomy (KP) is the primary surgical procedure for BA.
- Adjuvant therapies following KP lack established consensus, impacting patient outcomes.
Purpose of the Study:
- To evaluate the impact of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroids on clinical outcomes in BA patients post-KP.
- To analyze the rates of cholangitis, jaundice clearance, and native liver survival (NLS) within three years following KP.
Main Methods:
- Retrospective analysis of 54 BA patients undergoing KP between 1999-2018.
- Patients were divided into three groups based on PI-Abx duration and corticosteroid dosage: Group A (5-day PI-Abx), Group B (5-day PI-Abx + low-dose prednisolone), and Group C (14-day PI-Abx + high-dose prednisolone).
Main Results:
- No significant difference in cholangitis episodes between groups (p=NS).
- Jaundice clearance rates at 6 months and 3-year NLS rates showed no significant improvement with extended PI-Abx or corticosteroids (p=NS).
- Persistence of jaundice at 6 months was significantly associated with adverse outcomes like decompensated cirrhosis or death at 3 years (p<0.001).
Conclusions:
- Extended perioperative antibiotics and adjuvant corticosteroids do not appear to improve cholangitis rates, jaundice clearance, or native liver survival in biliary atresia patients post-Kasai portoenterostomy.
- Jaundice persistence is a critical indicator for long-term prognosis in BA patients.
Purpose:
There is no consensus regarding adjuvant therapies following Kasai portoenterostomy (KP) for biliary atresia (BA). This study aimed to analyze the effect of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroid on cholangitis and jaundice clearance rates in the 3 years post-KP in children with BA.
Methods:
Data of patients who underwent KP between 1999-2018 at a single center were retrospectively analyzed. Group A (1999-2010) received PI-Abx for 5 days, Group B (2010-2012) received PI-Abx for 5 days plus low-dose prednisolone (2 mg/kg), and Group C (2012-2017) received PI-Abx for 14 days plus high-dose prednisolone (5 mg/kg).
Results:
Fifty-four patients were included with groups A, B, and C comprising 25, 9, and 20 patients, respectively. The number of episodes of cholangitis was 1.0, 1.6, and 1.3 per patient (p=NS) within the first year and 1.8, 2.3, and 1.7 (p=NS) over 3 years in Groups A, B, and C, respectively. The jaundice clearance rate at 6 months was 52%, 78%, and 50% (p=NS), and the 3-year native liver survival (NLS) rate was 76%, 100%, and 80% (p=NS) in Groups A, B, and C, respectively. A near-significant association was observed between the incidence of cholangitis within the first year and decompensated liver cirrhosis/death at 3 years post KP (p=0.09). Persistence of jaundice at 6 months was significantly associated with decompensated cirrhosis/death at 3 years (p<0.001).
Conclusion:
The extended duration of PI-Abx and adjuvant corticosteroids was not associated with improved rates of cholangitis, jaundice clearance, or NLS in patients with BA.
Related Concept Videos
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Acute Pyelonephritis II: Diagnostic Studies and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:

